Literature DB >> 30510121

Lactic Acid Accumulation in the Tumor Microenvironment Suppresses 18F-FDG Uptake.

Silvan Türkcan1, Louise Kiru1, Dominik J Naczynski1, Laura S Sasportas2, Guillem Pratx3.   

Abstract

The process by which tumor cells take up 2-[18F]fluoro-2-deoxy-D-glucose (FDG) is heterogeneous and influenced by a multitude of factors. In mouse tumor grafts, the core of the tumor often presents lower FDG uptake than the periphery. Whether this pattern is caused by the intrinsic avidity of individual cells for FDG, the density of viable cells in the tumor, or the perfusion of the radiotracer remains unknown. In this study, we used radioluminescence microscopy to measure FDG uptake in single cells isolated from the core and periphery of the tumor and found that differences in FDG uptake persist on the level of single cells. Single cells from the core of 4T1 and MDA-MB-231 tumors grafts took up 26% to 84% less FDG than those from the periphery. These differences were observed in mice with large tumors (>8 mm diameter) but not in those with smaller tumors. To explain the origin of these differences, we examined the influence of three microenvironmental factors on FDG uptake. Hypoxia was ruled out as a possible explanation because its presence in the core would increase and not decrease FDG uptake. Higher cell proliferation in the periphery was consistent with higher FDG uptake, but there was no evidence of a causal relationship. Finally, lactate was higher in the core of the tumor, and it suppressed FDG uptake in a dose-dependent fashion. We therefore conclude that lactic acidosis-the combination of lactate ion buildup and acidic pH-can increase the heterogeneity of FDG uptake in MDA-MB-231 and 4T1 tumor grafts. SIGNIFICANCE: Analysis of single cells from heterogeneous tumors reveals the role played by the tumor microenvironment, lactic acidosis in particular, on the uptake by tumor cells of 18F-FDG, a PET imaging agent. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30510121      PMCID: PMC6335173          DOI: 10.1158/0008-5472.CAN-17-0492

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  High-resolution radioluminescence microscopy of 18F-FDG uptake by reconstructing the β-ionization track.

Authors:  Guillem Pratx; Kai Chen; Conroy Sun; Marian Axente; Laura Sasportas; Colin Carpenter; Lei Xing
Journal:  J Nucl Med       Date:  2013-09-03       Impact factor: 10.057

2.  Modular low-light microscope for imaging cellular bioluminescence and radioluminescence.

Authors:  Tae Jin Kim; Silvan Türkcan; Guillem Pratx
Journal:  Nat Protoc       Date:  2017-04-20       Impact factor: 13.491

3.  Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats.

Authors:  Ande Bao; William T Phillips; Beth Goins; Howard S McGuff; Xiangpeng Zheng; F Ross Woolley; Mohan Natarajan; Cristina Santoyo; Frank R Miller; Randal A Otto
Journal:  Otolaryngol Head Neck Surg       Date:  2006-12       Impact factor: 3.497

4.  Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR.

Authors:  M Rosner; M Hengstschläger
Journal:  Oncogene       Date:  2011-05-23       Impact factor: 9.867

Review 5.  Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients.

Authors:  L G Strauss
Journal:  Eur J Nucl Med       Date:  1996-10

6.  The TSC1 gene product, hamartin, negatively regulates cell proliferation.

Authors:  A Miloloza; M Rosner; M Nellist; D Halley; G Bernaschek; M Hengstschläger
Journal:  Hum Mol Genet       Date:  2000-07-22       Impact factor: 6.150

7.  Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts.

Authors:  Jason L J Dearling; Aiden A Flynn; Julie Sutcliffe-Goulden; Ingrid A Petrie; Robert Boden; Alan J Green; Geoffrey M Boxer; Richard H J Begent; R Barbara Pedley
Journal:  J Nucl Med       Date:  2004-01       Impact factor: 10.057

8.  HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.

Authors:  Ioanna Papandreou; Rob A Cairns; Lucrezia Fontana; Ai Lin Lim; Nicholas C Denko
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

9.  Radioluminescence microscopy: measuring the heterogeneous uptake of radiotracers in single living cells.

Authors:  Guillem Pratx; Kai Chen; Conroy Sun; Lynn Martin; Colin M Carpenter; Peter D Olcott; Lei Xing
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

10.  Optoacoustics delineates murine breast cancer models displaying angiogenesis and vascular mimicry.

Authors:  Isabel Quiros-Gonzalez; Michal R Tomaszewski; Sarah J Aitken; Laura Ansel-Bollepalli; Leigh-Ann McDuffus; Michael Gill; Lina Hacker; Joanna Brunker; Sarah E Bohndiek
Journal:  Br J Cancer       Date:  2018-03-26       Impact factor: 7.640

View more
  8 in total

1.  Flow radiocytometry using droplet optofluidics.

Authors:  Byunghang Ha; Tae Jin Kim; Ejung Moon; Amato J Giaccia; Guillem Pratx
Journal:  Biosens Bioelectron       Date:  2021-08-13       Impact factor: 12.545

2.  Microfluidics-Coupled Radioluminescence Microscopy for In Vitro Radiotracer Kinetic Studies.

Authors:  Tae Jin Kim; Byunghang Ha; Alison Dana Bick; Minkyu Kim; Sindy K Y Tang; Guillem Pratx
Journal:  Anal Chem       Date:  2021-03-01       Impact factor: 6.986

3.  Tussah silkmoth pupae improve anti-tumor properties of Cordyceps militaris (L.) Link by increasing the levels of major metabolite cordycepin.

Authors:  Zhixin Wen; Xingfan Du; Nan Meng; Yajie Li; Rui Mi; Xuejun Li; Yongxin Sun; Shuhui Ma; Shuying Li
Journal:  RSC Adv       Date:  2019-02-13       Impact factor: 4.036

Review 4.  Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter.

Authors:  Tord Hompland; Christina Sæten Fjeldbo; Heidi Lyng
Journal:  Cancers (Basel)       Date:  2021-01-28       Impact factor: 6.639

Review 5.  Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: a review.

Authors:  Lu Zhang; Wen Zhang; Ziye Li; Shumeng Lin; Tiansheng Zheng; Bingjie Hao; Yaqin Hou; Yanfei Zhang; Kai Wang; Chenge Qin; Liduo Yue; Jing Jin; Ming Li; Lihong Fan
Journal:  J Exp Clin Cancer Res       Date:  2022-07-21

6.  Autoregulation of H+/lactate efflux prevents monocarboxylate transport (MCT) inhibitors from reducing glycolytic lactic acid production.

Authors:  Wiktoria Blaszczak; Hannah Williams; Pawel Swietach
Journal:  Br J Cancer       Date:  2022-07-15       Impact factor: 9.075

7.  FDG uptake in cancer: a continuing debate.

Authors:  Silvia Peppicelli; Elena Andreucci; Jessica Ruzzolini; Francesca Bianchini; Lido Calorini
Journal:  Theranostics       Date:  2020-02-06       Impact factor: 11.556

Review 8.  Immunometabolism: new insights and lessons from antigen-directed cellular immune responses.

Authors:  Renata Ramalho; Martin Rao; Chao Zhang; Chiara Agrati; Giuseppe Ippolito; Fu-Sheng Wang; Alimuddin Zumla; Markus Maeurer
Journal:  Semin Immunopathol       Date:  2020-06-09       Impact factor: 9.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.